Francois Cedric

Chief Executive Officer

1 company

Excellent

Trades Analyzed

12M Win Rate

93.3%

Avg 3M Return

+7.6%

Avg 12M Return

+36.0%

Francois Cedric is a Chief Executive Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 17 sells.

Estimated insider holdings value: $19.8M based on current market prices.

Holdings by Company

APLSJan 28, 2026

Current Shares482.0K

Value$19.78M

Net Activity-1,156,104

Bought: 0Sold: 1.16M

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 29, 2024	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sell	2,843	$64.14	$182,344.90	-0.9%	-26.8%	-55.2%
Jan 22, 2024	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sell	13,431	$65.00	$872,961.28	-4.0%	-27.2%	-54.0%
Jan 16, 2024	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sell	7,851	$66.81	$524,514.32	-2.3%	-22.3%	-56.2%
Nov 21, 2023	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sell	5,000	$48.80	$244,000.00	-1.8%	+37.5%	-44.3%
Sep 1, 2023	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sale+OE	150,000	$41.75	$6,262,959.45	-14.9%	+23.9%	-10.5%
May 16, 2023	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sale+OE	30,000	$85.66	$2,569,900.13	-1.7%	-61.3%	-52.2%
Apr 18, 2023	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sale+OE	30,000	$82.02	$2,460,720.00	-4.5%	-36.1%	-41.5%
Mar 21, 2023	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sale+OE	30,000	$62.74	$1,882,332.00	-2.6%	+42.0%	-10.6%
Dec 19, 2022	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sale+OE	28,200	$52.06	$1,467,983.31	-1.4%	+21.1%	+11.4%
Dec 15, 2020	APLS Apellis Pharmaceuticals, Inc.	Chief Executive Officer	Sell	5,000	$52.16	$260,800.00	-0.4%	-	-